HLB Genex, Inc.
KOSDAQ
₩1,807.00
-1.47%
Delayed · cached 15 min
Fair value analysis
187420
HLB Genex, Inc.
₩1,807.00
Close used for this calculation
₩1,701.07Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
50/100
Quality radar
Consensus fair value
₩1,701.07
Near FV▼ -5.9% against the close used
Model range ₩254.07 – ₩10,447.78
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩254.07Fair value₩1,701.07Bull₩10,447.78
FairClose
52-week traded range
52W low ₩1,373.0052W high ₩2,005.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading close to the consensus fair value
HLB Genex, Inc. closed at ₩1,807.00, 6.2% above the consensus fair value of ₩1,701.07 drawn from 3 valuation models.
Financial DNA score 50/100 — Good. P/E of 2.3x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩1,701.07
-5.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
EV/EBITDA
₩254.07
-85.9%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=1.21B
Book Value (P/B)
₩10,447.78
+478.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=1400.78, ROE=55.2%, g=3%, r=10%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.